A public health collaboration for the surveillance of autism spectrum disorders
- PMID:17302648
- DOI: 10.1111/j.1365-3016.2007.00801.x
A public health collaboration for the surveillance of autism spectrum disorders
Abstract
Autism spectrum disorders (ASDs) represent a range of behavioural phenotypes defined by impaired development in social interaction, communication, imagination, and range of interests or behaviours. The aetiology and epidemiology of these serious developmental disabilities (DDs) are poorly understood. Estimates of the population prevalence of ASDs have varied widely within the US and abroad, with increasing estimates in most of the recent studies. In an effort to improve our understanding of the prevalence, population characteristics and public health impact of these conditions, the Centers for Disease Control and Prevention has funded a multi-site surveillance network for ASDs and other DDs that consists of programmes known as the Autism and Developmental Disabilities Monitoring (ADDM) network which conducts surveillance activities and the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) which also conducts surveillance in addition to special research studies related to the ASDs. This collaboration will be referred to hereafter as the ADDM Network. The ADDM Network is implementing a multiple-source surveillance programme to determine population prevalence and characteristics of ASDs and other DDs. This paper describes the collaborative efforts and explains the methods in developing this coordinated public health surveillance network to provide an ongoing source of high-quality data on ASDs.
Similar articles
- Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002.Van Naarden Braun K, Pettygrove S, Daniels J, Miller L, Nicholas J, Baio J, Schieve L, Kirby RS, Washington A, Brocksen S, Rahbar H, Rice C; Centers for Disease Control and Prevention.Van Naarden Braun K, et al.MMWR Surveill Summ. 2007 Feb 9;56(1):29-40.MMWR Surveill Summ. 2007.PMID:17287716
- Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders.Rice C, Schendel D, Cunniff C, Doernberg N.Rice C, et al.Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):22-7. doi: 10.1002/ajmg.c.30006.Am J Med Genet C Semin Med Genet. 2004.PMID:14755430Review.
- Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators; Centers for Disease Control and Prevention.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators, et al.MMWR Surveill Summ. 2007 Feb 9;56(1):1-11.MMWR Surveill Summ. 2007.PMID:17287714
- Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention.Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, et al.MMWR Surveill Summ. 2012 Mar 30;61(3):1-19.MMWR Surveill Summ. 2012.PMID:22456193
- Healthcare for children with autism: the Autism Treatment Network.Coury D, Jones NE, Klatka K, Winklosky B, Perrin JM.Coury D, et al.Curr Opin Pediatr. 2009 Dec;21(6):828-32. doi: 10.1097/MOP.0b013e328331eaaa.Curr Opin Pediatr. 2009.PMID:19745738Review.
Cited by
- Frequency and pattern of documented diagnostic features and the age of autism identification.Maenner MJ, Schieve LA, Rice CE, Cunniff C, Giarelli E, Kirby RS, Lee LC, Nicholas JS, Wingate MS, Durkin MS.Maenner MJ, et al.J Am Acad Child Adolesc Psychiatry. 2013 Apr;52(4):401-413.e8. doi: 10.1016/j.jaac.2013.01.014.J Am Acad Child Adolesc Psychiatry. 2013.PMID:23582871Free PMC article.
- Vasopressin in the Amelioration of Social Functioning in Autism Spectrum Disorder.Hendaus MA, Jomha FA, Alhammadi AH.Hendaus MA, et al.J Clin Med. 2019 Jul 19;8(7):1061. doi: 10.3390/jcm8071061.J Clin Med. 2019.PMID:31331023Free PMC article.Review.
- Concordance between a U.S. Educational Autism Classification and the Autism Diagnostic Observation Schedule.Maddox BB, Rump KM, Stahmer AC, Suhrheinrich J, Rieth SR, Nahmias AS, Nuske HJ, Reisinger EM, Crabbe SR, Bronstein B, Mandell DS.Maddox BB, et al.J Clin Child Adolesc Psychol. 2020 Jul-Aug;49(4):469-475. doi: 10.1080/15374416.2019.1567345. Epub 2019 Mar 20.J Clin Child Adolesc Psychol. 2020.PMID:30892948Free PMC article.
- The impact of surveillance method and record source on autism prevalence: collaboration with Utah Maternal and Child Health programs.Pinborough-Zimmerman J, Bilder D, Satterfield R, Hossain S, McMahon W.Pinborough-Zimmerman J, et al.Matern Child Health J. 2010 May;14(3):392-400. doi: 10.1007/s10995-009-0472-3. Epub 2009 May 28.Matern Child Health J. 2010.PMID:19475366
- Using an integrated ontology and information model for querying and reasoning about phenotypes: The case of autism.Tu SW, Tennakoon L, O'Connor M, Shankar R, Das A.Tu SW, et al.AMIA Annu Symp Proc. 2008 Nov 6;2008:727-31.AMIA Annu Symp Proc. 2008.PMID:18999231Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources